4 Health Care Stocks On The Rise

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 57 points (-0.4%) at 15,601 as of Monday, Aug. 5, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,233 issues advancing vs. 1,686 declining with 120 unchanged.

The Health Care sector currently sits up 0.6% versus the S&P 500, which is down 0.2%. Top gainers within the sector include WellPoint ( WLP), up 2.4%, HCA Holdings ( HCA), up 1.8%, Illumina ( ILMN), up 1.5%, UnitedHealth Group ( UNH), up 1.3% and Aetna ( AET), up 1.2%. On the negative front, top decliners within the sector include Valeant Pharmaceuticals International ( VRX), down 1.6%, Vertex Pharmaceuticals ( VRTX), down 1.2%, Shire ( SHPG), down 1.2%, Agilent Technologies ( A), down 1.1% and AstraZeneca ( AZN), down 1.0%.

TheStreet would like to highlight 4 stocks pushing the sector higher today:

4. Alkermes ( ALKS) is one of the companies pushing the Health Care sector higher today. As of noon trading, Alkermes is up $1.26 (3.8%) to $34.89 on average volume. Thus far, 1.0 million shares of Alkermes exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $33.63-$35.58 after having opened the day at $33.85 as compared to the previous trading day's close of $33.63.

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. Alkermes has a market cap of $4.6 billion and is part of the drugs industry. Shares are up 81.9% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Alkermes a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates Alkermes as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. Get the full Alkermes Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Tenet Healthcare ( THC) is up $1.81 (4.1%) to $45.74 on average volume. Thus far, 687,678 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $43.79-$45.80 after having opened the day at $43.94 as compared to the previous trading day's close of $43.93.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.6 billion and is part of the health services industry. Shares are up 36.7% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. Get the full Tenet Healthcare Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Humana ( HUM) is up $1.42 (1.6%) to $91.31 on light volume. Thus far, 497,906 shares of Humana exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $89.89-$91.56 after having opened the day at $89.89 as compared to the previous trading day's close of $89.89.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $14.4 billion and is part of the health services industry. Shares are up 31.0% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Humana Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Cigna ( CI) is up $1.04 (1.4%) to $78.34 on light volume. Thus far, 502,430 shares of Cigna exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $76.63-$78.47 after having opened the day at $77.19 as compared to the previous trading day's close of $77.30.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $22.0 billion and is part of the health services industry. Shares are up 44.5% year to date as of the close of trading on Friday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Cigna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Stocks Lower as Energy Shares Fall on Drop in Oil Prices

Stocks Lower as Energy Shares Fall on Drop in Oil Prices

Italian Bonds Slump as Government Mulls Anti-Euro Finance Minister

Italian Bonds Slump as Government Mulls Anti-Euro Finance Minister

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

One Thing to Consider Over Memorial Day Weekend: Are Stocks About to Collapse?

One Thing to Consider Over Memorial Day Weekend: Are Stocks About to Collapse?

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

North Korea, Apple, GPDR and Gap - 5 Things You Must Know